Please use this identifier to cite or link to this item:
Title: Electrolyte imbalances as poor prognostic markers in COVID-19: a systemic review and meta-analysis
Authors: Song, HJJMD
Chia, AZQ
Tan, BKJ
Teo, CB
Lim, V
Chua, HR
Samuel, M
Kee, A 
Keywords: Death risk
Intensive care
Respiratory medicine
Severe acute respiratory syndrome
Issue Date: 1-Jan-2022
Publisher: Springer Science and Business Media LLC
Citation: Song, HJJMD, Chia, AZQ, Tan, BKJ, Teo, CB, Lim, V, Chua, HR, Samuel, M, Kee, A (2022-01-01). Electrolyte imbalances as poor prognostic markers in COVID-19: a systemic review and meta-analysis. Journal of Endocrinological Investigation : 1-25. ScholarBank@NUS Repository.
Abstract: Purpose: Serum electrolyte imbalances are highly prevalent in COVID-19 patients. However, their associations with COVID-19 outcomes are inconsistent, and of unknown prognostic value. We aim to systematically clarify the associations and prognostic accuracy of electrolyte imbalances (sodium, calcium, potassium, magnesium, chloride and phosphate) in predicting poor COVID-19 clinical outcome. Methods: PubMed, Embase and Cochrane Library were searched. Odds of poor clinical outcome (a composite of mortality, intensive-care unit (ICU) admission, need for respiratory support and acute respiratory distress syndrome) were pooled using mixed-effects models. The associated prognostic sensitivity, positive and negative likelihood ratios (LR + , LR-) and predictive values (PPV, NPV; assuming 25% pre-test probability), and area under the curve (AUC) were computed. Results: We included 28 observational studies from 953 records with low to moderate risk-of-bias. Hyponatremia (OR = 2.08, 95% CI = 1.48–2.94, I2 = 93%, N = 8), hypernatremia (OR = 4.32, 95% CI = 3.17–5.88, I2 = 45%, N = 7) and hypocalcemia (OR = 3.31, 95% CI = 2.24–4.88, I2 = 25%, N = 6) were associated with poor COVID-19 outcome. These associations remained significant on adjustment for covariates such as demographics and comorbidities. Hypernatremia was 97% specific in predicting poor outcome (LR + 4.0, PPV = 55%, AUC = 0.80) despite no differences in CRP and IL-6 levels between hypernatremic and normonatremic patients. Hypocalcemia was 76% sensitive in predicting poor outcome (LR- 0.44, NPV = 87%, AUC = 0.71). Overall quality of evidence ranged from very low to moderate. Conclusion: Hyponatremia, hypernatremia and hypocalcemia are associated with poor COVID-19 clinical outcome. Hypernatremia is 97% specific for a poor outcome, and the association is independent of inflammatory marker levels. Further studies should evaluate if correcting these imbalances help improve clinical outcome.
Source Title: Journal of Endocrinological Investigation
ISSN: 0391-4097
DOI: 10.1007/s40618-022-01877-5
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Electrolyte imbalances as poor prognostic markers in COVID-19 a systemic review and meta-analysis.pdfPublished version5.74 MBAdobe PDF



Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.